Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Should You Be Bullish on Home Bancshares Inc (HOMB), Calpine Corporation (CPN) & Two Other Stocks?

Are Home Bancshares Inc (NASDAQ:HOMB), Calpine Corporation (NYSE:CPN), Pacira Pharmaceuticals Inc (NASDAQ:PCRX), and Rent-A-Center Inc (NASDAQ:RCII) stocks that should be part of your portfolio? According to our research, beating the market is possible by imitating the moves of smart money investors, and one fund that was bullish on all these four companies heading into the last quarter was Alex Lieblong‘s Key Colony Management.

The value of Key Colony Management’s equity portfolio jumped to $83.18 million from $78.49 million during the third quarter. The fund’s seven ‘relevant’ long positions brought a positive return of 15.05% in the third quarter. In our methodology, we include holdings in companies that had a market cap of at least $1 billion at the end of a particular quarter. Although these returns differ from the fund’s actual returns as they don’t include short positions and some other instruments, they still provide us with a guidance when it comes to assessing whether or not it is worth imitating the fund’s investment moves. Therefore, we are going to examine Key Colony Management’s positions in the aforementioned companies and see how did they perform in the third quarter.

stocks, analysis, market, numbers, business, ticker, trade, money, price, investment, index, chart


Key Colony Management lowered its stake in Home Bancshares Inc (NASDAQ:HOMB) by 2%, twice, in second and third quarter, reporting a position of 1.12 million shares worth $23.41 million as of the end of September. During the third quarter, the stock appreciated by 5.6%. At the end of June, a total of 13 funds tracked by Insider Monkey were long this stock, an increase of 44% from the previous quarter. One of the biggest shareholders of Home Bancshares Inc (NASDAQ:HOMB) was Forest Hill Capital, which amassed a stake valued at $22 million at the end of June. Skylands Capital, Mendon Capital Advisors, and Cupps Capital Management also held valuable positions in the company.

Follow Home Bancshares Inc (NASDAQ:HOMB)
Trade (NASDAQ:HOMB) Now!

In power generation company, Calpine Corporation (NYSE:CPN), Key Colony Management had lowered its stake by 5% to 649,054 shares in the second quarter and closed the position entirely in the following three months as the stock slid by 14.3% in the same period. Heading into the third quarter of 2016, 32 from our database held long positions in this stock, down by 11% sequentially. Among these funds, Viking Global held the most valuable stake in Calpine Corporation (NYSE:CPN), which was worth $300.4 million at the end of the second quarter. On the second spot was Carlson Capital which amassed $183 million worth of shares. Moreover, Point State Capital, GoldenTree Asset Management, and Greenlight Capital were also bullish on Calpine Corporation (NYSE:CPN).

Follow Calpine Corp (NYSE:CPN)
Trade (NYSE:CPN) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.